NCT03486990 - Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

May 24, 2019

Study Completion Date

July 22, 2019

Conditions

Celiac Disease

Interventions

DRUG

TIMP-GLIA

intravenous infusion.

Trial Locations (4)

Jacksonville Center For Clinical Research, Jacksonville

Prism Clinical Research, Saint Paul

Mayo Gastroenterology Research Unit, Rochester

Mass General Hospital Translational and Clinical Research Centers, Boston